Joined January 2016
- Tweets107
- Following247
- Followers162
- Likes950
Doreen Chan retweeted
$AKRO announced the publication of results from the Phase 2b SYMMETRY study in @NEJM. Results support the potential benefit of #EFX to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to #MASH.
Learn more: nejm.org/doi/full/10.1056/NE…
Doreen Chan retweeted
Greetings from San Diego! #TeamAkero had the pleasure of attending this year’s @AASLDtweets The Liver Meeting 2024 to connect with leading experts, share our latest data and insights, and engage in inspiring discussions about the future of MASH treatment.
#TLM24 #Biotech
Doreen Chan retweeted
On my first day at the @Stanford @AppelGroup in 2018, my labmates @doreencchan, @HectorLopezPhD, and @antcyu took me to In-N-Out. Fast forward to 2024, and we reunited yesterday! It’s wild to realize that I moved to California over 6 years ago. Time flies, but good friends last!
Congrats Dr Victor Miller! Attended my first in person defense since pre COVID 😱 Thanks for sharing your work on low temperature plasma towards renewable fertilizer! – at Berkeley, CA
5
229
Congrats Eric! 🎉🥳 – at Oakland, CA
I'm happy to announce that I've been awarded tenure @stanford @StanfordMSE! I'm so very thankful to all of the @AppelGroup members past and present for helping to build a vibrant, creative, collaborative, and fun community within the lab. What a day! (1/2)
2
382
Doreen Chan retweeted
#TeamAkero had a blast at #KSNASH23 in beautiful Alberta, Canada! Learn more about #EFX and its potential to treat #NASH by addressing all core drivers of disease progression by visiting us at akerotx.com/ #LiverTwitter @KeystoneSymp
Check out our posters! 👇
This week, #TeamAkero presents on the potential of #EFX to treat #NASH at the whole-body level at #KSNASH23 – check out the posters at bit.ly/3JzyOns #LiverTwitter @KeystoneSymp
3
337
Looking forward to the week at the Keystone Symposia in Banff! Can’t beat the view. – at Banff, Alberta
1
11
1,755
🔬Apply the selected hydrogel coating onto PDMS and insulin pumps
🔬Extend lifetime and shown improved biocompatibility of implanted pumps
Thanks @CMaikawa @AndreadAquino7 and collaborators at Stanford! ⭐️⭐️
Check it out here 👉doi.org/10.1002/jbm.a.37521 2/2 – at Oakland, CA
happy to share my work from the @AppelGroup on extending the longevity of implanted devices through hydrogel coatings!
🔬We synthesize and screen a subset library of hydrogels for biocompatibility in mice
🔬Demonstrate improvement over gold standard materials. 1/2 – at Oakland, CA
Doreen Chan retweeted
$AKRO is excited to announce that the @US_FDA has granted Breakthrough Therapy Designation to #EFX for the treatment of #NASH. Read more: bit.ly/3ULMX4C #LiverTwitter
Doreen Chan retweeted
$AKRO had a great time at #TLM22! We’re honored to have our HARMONY data presentation selected for inclusion in the “Best of the Liver Meeting” in the NALFD/#NASH category! Learn more & see top presentations: bit.ly/3UnQUgw #LiverMtg22 #LiverTwitter #EFX @AALSDtweets
excited to be at #aasld #thelivermeeting in DC this weekend! first in person conference since 2019!
5
Doreen Chan retweeted
My colleague @doreencchan forgot to mention that a member of her PhD thesis committee is now a Nobel Prize! @CarolynBertozzi 💫💫💫
A huge congrats to the recipients of the Nobel Prize in Chemistry! 🙌🙌🙌 – at Los Angeles, CA
BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the 2022 #NobelPrize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry.”
Doreen Chan retweeted
$AKRO reports positive, statistically significant topline results for both #EFX doses on key histology endpoints in the Ph2b HARMONY study of EFX in F2/F3 #NASH #fibrosis: bit.ly/3Dleyo3 Tune in to the data presentation at 8AM ET to learn more: bit.ly/3L3U9Ww
Doreen Chan retweeted
An @AppelGroup Dream Team! Check out our paper in Matter!
Throughout 2022, Matter is spotlighting a first author every month.
Congrats @SantiCorreaPhD & @Abigail_kate95 from @AppelGroup @StanfordMSE @StanfordEng, our #MatterAuthorSpotlight for June 2022!
Lab website: supramolecularbiomaterials.c…
Matter paper: bit.ly/3Q7EJmd
ALT Matter Author Spotlight, June 2022. Santiago Correa, Postdoctoral Fellow, Stanford & Incoming Asst. Prof., Columbia. Research Area: Nanotechnology and supramolecular biomaterials for immunoengineering with a focus on the role of nanoparticle surface chemistry. Abigail K. Grosskopf, 5th year Ph.D. student, Stanford. Research Area: Design of hydrogel materials for applications in therapeutic cell delivery, drug delivery and 3D printing. Paper: Injectable liposome-based supramolecular hydrogels for the programmable release of multiple protein drugs Matter 5(6) p. 1816–1838
2 years delayed, but better late than never! So great to be back on Stanford campus and to celebrate in person.
2
78
Doreen Chan retweeted
Some really cool work by @doreencchan and @AppelGroup on a smarter approach to developing anti-biofouling coatings for biosensors. Thanks for another great collaboration!
Been meaning to do a bit of tweetorial on @doreencchan's work on anti-biofouling coatings for #biosensors and other medical devices. Biofouling on these devices severely hinders functionality and lifetime, so coating technologies are needed to improve their function.
